DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
NCT00003066
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
estramustine phosphate sodium
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDocetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Herbert Irving Comprehensive Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003066 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.